References
- Auersperg N, Edelson M I, Mok S C, et al. The biology of ovarian cancer. Semin Oncol 1998; 25: 281–304
- Daly M, Iris Obrams G. Epidemiology and risk assessment for ovarian cancer. Semin Oncol 1998; 25: 225–64
- Osterholzer H O, Johnson J H, Nicosia S V. An autoradiographic study of rabbit ovarian surface epithelium before and after ovulation. Biol Reprod 1985; 33: 729–38
- Murdoch W J. Ovarian surface epithelium during ovulatory and anovulatory ovine estrous cycles. Anat Rec 1994; 240: 322–6
- Fredrickson T N. Ovarian tumors of the hen. Environ Health Prespect 1987; 73: 35–51
- Schildkraut J M, Bastos E, Berchuck A. Relationship between lifetime ovulatory cycles and over-expression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 1997; 89: 932–8
- Nicosia S V, Narconis R J, Saunders B O. Influence of a corpus luteum extract on rabbit ovarian mesothelial cells. Scanning Microsc 1994; 8: 393–402
- Murdoch W J. Programmed cell death in preovulatory ovine follicles. Biol Reprod 1995; 53: 8–12
- Wynford-Thomas D, Williams E D. Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet 1986; 19: 179–81
- Wright N, Alison M. Methodology in epithelial cell kinetics. The Biology of Epithelial Cell Populations. Oxford Science Publications, Oxford 1984; 1: 97–203
- Kaufman M H. The Atlas of Mouse Development. Academic Press, London 1992; 453–65
- Murphy E D. Hyperplastic and early neoplastic changes in the ovaries of mice after genic deletion of germ cells. J Natl Cancer Inst 1972; 48: 1283–95
- Blaakaer J, Baeksted M, Micic S, et al. Gonadotrophin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype. Biol Reprod 1995; 53: 775–9
- Schiffenbauer Y S, Abramovitch R, Meir G, et al. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 1997; 94: 13203–8
- Fishel S, Jackson P. Follicular stimulation for high tech pregnancies: are we playing it safe?. BMJ 1989; 299: 309–11
- Dietl J. Ovulation and ovarian cancer. Lancet 1991; 338: 445
- Balasch J, Barri P N. Follicular stimulation and ovarian cancer?. Hum Reprod 1993; 8: 990–6
- Rossing M A, Daling J R, Weiss N S, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771–6
- Grimbizis G, Tarlatzis B C, Bontis J, et al. Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts. Hum Reprod 1995; 10: 520–3
- Kuroda H, Konishi I, Mandai M, et al. Ovarian cancer in fertile women during or after ovulation induction therapy: expression of LH/hCG receptors and sex steroid receptors. Intl J Gynecol Cancer 1997; 7: 451–7
- Franceschi S, La Vecchia C, Negri E, et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994; 9: 1673–5
- Mosgaard B J, Schou G, Lidegaard O, et al. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997; 67: 1005–12
- Whittemore A S, Wu M L, Paffenbarger R S, et al. Epithelial ovarian cancer and the ability to conceive. Cancer Res 1989; 49: 4047–52
- Zheng W, Magid M S, Kramer E E, et al. Follicle stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 1996; 148: 47–53
- Osterholzer H O, Striebel E J, Nicosia S V. Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod 1985; 33: 247–58
- Adams A T, Auersperg N. A cell line, ROSE 199, derived from normal rat ovarian surface epithelium. Exp Cell Biol 1985; 53: 181–8
- Stouffer R L, Grodin M S, Davis J R, et al. Investigation of binding sites for follicle stimulating hormone and chorionic gonadotrophin in human ovarian cancers. J Clin Endocrinol Metab 1984; 59: 441–6
- Parrott J A, Vigne J L, Chu B Z, et al. Mesenchymal-epithelial interactions in the ovarian follicle involve keratinocyte and hepatocyte growth factor production by thecal cells and their action on granulosa cells. Endocrinology 1994; 135: 569–75